Companies: 10,795·Total market cap: $144.5T
Labcorp Holdings Inc.

Labcorp Holdings Inc.

LHNYSEHealthcare● Active
$265.15
+$4.18(+1.60%)
Market Cap$21.7B
P/E Ratio—
52W High$293.72
52W Low$241.81
Overview
Stock ranking:Medical - Diagnostics & Research·Healthcare·View All Market Cap Rankings →

Labcorp Holdings Inc. (LH) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LH · as of Jun 8, 2026

Key Statistics

EPS (TTM)$11.37lh eps ttm · lh earnings per shareEarnings history
PE Ratio (TTM)23.3×lh pe ratio ttm · lh price to earningsPE Ratio deep dive
Revenue (TTM)$14.1Blh revenue ttm · lh annual revenueFull revenue history
Dividend Yield1.11%does lh pay dividends · lh dividend yieldDividend history
Shares Outstanding83.2Mlh shares outstanding · lh floatShares outstanding history
Next EarningsJul 23, 2026Est.lh earnings date · lh next earningsEarnings history

Explore Labcorp Holdings Inc. Data

lh stock data · financials
Market Cap$21.7Blh market cap · lh valuation
Analyst Forecast$311 · Buy
Dividends1.11%does labcorp holdings inc. pay dividends · lh dividend yield
Revenue$14.0B+7.25%labcorp holdings inc. annual revenue · lh revenue
EarningsEPS $10.54+18.56%lh earnings · lh eps
PE Ratio23.3×lh pe ratio · lh price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$13.95B▲ +7.25% YoY
202320242025
labcorp holdings inc. revenue · lh revenue 2025
FY 2025Net Income$876.5M▲ +17.49% YoY
202320242025
labcorp holdings inc. net income · lh profit 2025
FY 2025EPS$10.54▲ +18.56% YoY
202320242025
lh eps · labcorp holdings inc. earnings per share 2025
TTM:Revenue: $14.14BNet Income: $941.5MEPS: $11.37View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy35 analystsis lh a buy · lh analyst rating
Strong Buy
0
Buy
26
Hold
9
Sell
0
Strong Sell
0
12-Month Price Target
$300.00Low
$265.15Current
$311.33Avg Target17.42% upside
$334.00High
lh price target · lh 12 month forecast

Total: 35 · Buy rate: 74.3%

The LH analyst consensus is Buy, based on ratings from 35 Wall Street analysts over the past 3 months. The average 12-month price target is $311.33, representing +17.42% upside from the current price of $265.15.

Stock Performance

Full History
1D+1.60%
1W+3.09%
1M+4.34%
3M-1.68%
YTD+5.69%
1Y+3.68%
5Y+18.52%

About Labcorp Holdings Inc.

CEOAdam H. Schechter
IPO DateMar 29, 1990
Employees60,900
CountryUS
Websitelabcorp.com

Labcorp Holdings Inc. Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April …

Medical - Diagnostics & ResearchHealthcareNYSEUS

what is labcorp holdings inc. · lh stock overview · labcorp holdings inc. company profile · who is labcorp holdings inc. ceo · lh NYSE · labcorp holdings inc. headquarters · labcorp holdings inc. business segments

About Stock Overview & Key Data

Labcorp Holdings Inc. (LH) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Mar 29, 1990. As of the latest trading session, LH stock price is $265.15, with a market capitalization of $21.7B. The stock has returned +3.68% over the past 12 months and +5.69% year-to-date.

According to 35 Wall Street analysts, the consensus rating for Labcorp Holdings Inc. stock is Buy, with an average 12-month price target of $311.33. In fiscal year 2025, Labcorp Holdings Inc. reported revenue of $14.0B and net income of $876.5M. For detailed data — including Labcorp Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Labcorp Holdings Inc. (LH) stock price is $265.15. The stock is traded on NYSE under the ticker symbol LH. The 52-week range is $241.81 – $293.72.

LH stock priceLH quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice